Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Finasteride reduces heart enlargement and improves heart function.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Finasteride effectively treats hair loss and prostate issues by blocking a specific enzyme.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

The new compound may be a safer alternative to finasteride for prostate protection.

No link found between specific genes and female pattern hair loss.

Finasteride safely lowers DHT levels without affecting testosterone.

The improved process makes Finasteride suitable for industrial production.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.